NT5E and breast carcinoma: As ZOL demonstrated the most effective growth inhibition of cells in vitro, we next compared effects of ZOL on sh-NT and sh-CD73 tumor growth in vivo, using an immune-competent, mammary fat pad mouse model of breast cancer (Figure 3A).